Company news
Simcere Pharmaceutical Group Limited news in 2021
Simcere Pharmaceutical Group Limited's news releases, calls and decks from 2021, newest first.
Simcere Pharmaceutical Group: Further announcement profit forecast in relation to disposal of subsidiaries
April 28, 2021
Simcere Pharmaceutical Group: Voluntary announcement in relation to the approval on clinical trial application for the addition of new indications of trilaciclib for injection
April 16, 2021
Change in use of proceeds
April 15, 2021
Simcere Pharmaceutical Group: Voluntary announcement in relation to the clinical trial approval for sim-307 issued by the center for drug evaluation of national medical products administration of prc
April 13, 2021
Resignation of executive director and chief operating officer
March 31, 2021
Simcere Pharmaceutical Group: Revised Terms of Reference of the Strategy Committee
March 25, 2021
Simcere Pharmaceutical Group: Voluntary announcement in relation to the approval of phase iii clinical trial application for addition of new indication for endostar by the national medical products administration of china
March 21, 2021